BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22953684)

  • 21. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
    Longobardi L; O'Rear L; Aakula S; Johnstone B; Shimer K; Chytil A; Horton WA; Moses HL; Spagnoli A
    J Bone Miner Res; 2006 Apr; 21(4):626-36. PubMed ID: 16598383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of potentials between stem cells isolated from human anterior cruciate ligament and bone marrow for ligament tissue engineering.
    Cheng MT; Liu CL; Chen TH; Lee OK
    Tissue Eng Part A; 2010 Jul; 16(7):2237-53. PubMed ID: 20163211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary study of mesenchymal stem cells-seeded type I collagen-glycosaminoglycan matrices for cartilage repair.
    Xiang Z; Hu W; Kong Q; Zhou H; Zhang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Feb; 20(2):148-54. PubMed ID: 16529325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix.
    Wilcox HE; Korossis SA; Booth C; Watterson KG; Kearney JN; Fisher J; Ingham E
    J Heart Valve Dis; 2005 Mar; 14(2):228-36; discussion 236-7. PubMed ID: 15792184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering.
    Appleton AJ; Appleton CT; Boughner DR; Rogers KA
    Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic fibroblast growth factor stimulates the release of preformed transforming growth factor beta 1 from human proximal tubular cells in the absence of de novo gene transcription or mRNA translation.
    Phillips AO; Topley N; Morrisey K; Williams JD; Steadman R
    Lab Invest; 1997 Apr; 76(4):591-600. PubMed ID: 9111519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage.
    Narita Y; Yamawaki A; Kagami H; Ueda M; Ueda Y
    Cell Tissue Res; 2008 Sep; 333(3):449-59. PubMed ID: 18607632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells.
    Huang Q; Wang YD; Wu T; Jiang S; Hu YL; Pei GX
    Chin Med J (Engl); 2009 Jan; 122(1):83-7. PubMed ID: 19187622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model.
    Mrugala D; Bony C; Neves N; Caillot L; Fabre S; Moukoko D; Jorgensen C; Noël D
    Ann Rheum Dis; 2008 Mar; 67(3):288-95. PubMed ID: 17644536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research on promoting periodontal regeneration with human basic fibroblast growth factor-modified bone marrow mesenchymal stromal cell gene therapy.
    Tan Z; Zhao Q; Gong P; Wu Y; Wei N; Yuan Q; Wang C; Liao D; Tang H
    Cytotherapy; 2009; 11(3):317-25. PubMed ID: 19308772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tailored release of TGF-beta1 from porous scaffolds for cartilage tissue engineering.
    Sohier J; Hamann D; Koenders M; Cucchiarini M; Madry H; van Blitterswijk C; de Groot K; Bezemer JM
    Int J Pharm; 2007 Mar; 332(1-2):80-9. PubMed ID: 17056215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling nucleus pulposus regeneration in vitro: mesenchymal stem cells, alginate beads, hypoxia, bone morphogenetic protein-2, and synthetic peptide B2A.
    McCanless JD; Cole JA; Slack SM; Bumgardner JD; Zamora PO; Haggard WO
    Spine (Phila Pa 1976); 2011 Dec; 36(26):2275-85. PubMed ID: 21311397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
    Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of xenogeneic extracellular matrix fabricated from CuCl
    Du HC; Jiang L; Geng WX; Li J; Zhang R; Dang JG; Shu MG; Li LW
    J Biomater Appl; 2017 Oct; 32(4):472-483. PubMed ID: 28927334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of bone engineering by means of growth factors in a three-dimensional matrix.
    Arnold U; Schweitzer S; Lindenhayn K; Perka C
    J Biomed Mater Res A; 2003 Oct; 67(1):260-9. PubMed ID: 14517885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet-rich plasma as a potential tool for tissue repair and regeneration.
    Formigli L; Benvenuti S; Mercatelli R; Quercioli F; Tani A; Mirabella C; Dama A; Saccardi R; Mazzanti B; Cellai I; Zecchi-Orlandini S
    J Tissue Eng Regen Med; 2012 Feb; 6(2):125-34. PubMed ID: 21351374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular potency of Sus scrofa bone marrow-derived mesenchymal stem cells: a progenitor source of medial but not endothelial cells.
    van den Akker NM; Kolk FF; Jeukens F; Verbruggen S; Gagliardi M; Dullens S; Heschel I; Post MJ; Molin DG; Waltenberger J
    Tissue Eng Part A; 2012 Apr; 18(7-8):828-39. PubMed ID: 22011280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary characterization of porcine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor.
    Thomson BM; Bennett J; Dean V; Triffitt J; Meikle MC; Loveridge N
    J Bone Miner Res; 1993 Oct; 8(10):1173-83. PubMed ID: 8256654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factor combination for chondrogenic induction from human mesenchymal stem cell.
    Indrawattana N; Chen G; Tadokoro M; Shann LH; Ohgushi H; Tateishi T; Tanaka J; Bunyaratvej A
    Biochem Biophys Res Commun; 2004 Jul; 320(3):914-9. PubMed ID: 15240135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Cytotoxic Crosslinkers for Heart Valve Tissue Engineering.
    Somers P; Roosens A; De Somer F; Cornelissen M; Van Nooten G
    J Heart Valve Dis; 2015 Jan; 24(1):92-100. PubMed ID: 26182626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.